Deborah Ashcraft
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotic Resistance in Bacteria 18
-
- Bacterial Identification and Susceptibility Testing 11
- Co-authors
- George A. PankeyK E AldridgeKenneth E. AldridgeCarl L. PiersonStephen G. JenkinsJon E. RosenblattK M CambreDavid J. Farrell
- Journals
- Antimicrobial Agents and Chemotherapy (8 papers)Diagnostic Microbiology and Infectious Disease (5 papers)Journal of Investigative Medicine (3 papers)Journal of Clinical Microbiology (1 paper)Medical Mycology (1 paper)
- Partner nations
- United StatesAustraliaJordan
In The Last Decade
Deborah Ashcraft
30 papers receiving 886 citations
Peers
Comparison fields: 5 of 78
- Molecular Medicine 364
- Clinical Biochemistry 292
- Applied Microbiology and Biotechnology 82
- Infectious Diseases 379
- Endocrinology 89
Countries citing papers authored by Deborah Ashcraft
This map shows the geographic impact of Deborah Ashcraft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Ashcraft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Ashcraft more than expected).
Fields of papers citing papers by Deborah Ashcraft
This network shows the impact of papers produced by Deborah Ashcraft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Ashcraft. The network helps show where Deborah Ashcraft may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Deborah Ashcraft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 11 | |
| 4 | 2020 | 15 | |
| 5 | 2020 | 15 | |
| 6 | 2020 | 5 | |
| 7 | 2019 | 1 | |
| 8 | 2019 | 42 | |
| 9 | 2018 | 12 | |
| 10 | Colistin and Polymyxin B Minimal Inhibitory Concentrations Determined by Etest Found Unreliable for Gram-Negative Bacilli. | 2017 | 26 |
| 11 | 2016 | 4 | |
| 12 | 2016 | 14 | |
| 13 | 2013 | 36 | |
| 14 | 2011 | 27 | |
| 15 | 2010 | 5 | |
| 16 | 2009 | 18 | |
| 17 | 2009 | 36 | |
| 18 | 2005 | 59 | |
| 19 | 2005 | 69 | |
| 20 | 2002 | 45 |
About Deborah Ashcraft
Deborah Ashcraft is a scholar working on Molecular Medicine, Clinical Biochemistry, Applied Microbiology and Biotechnology, Endocrinology and Infectious Diseases, having authored 30 papers that have together received 915 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (18 papers), Bacterial Identification and Susceptibility Testing (11 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Streptococcal Infections and Treatments (5 papers), Antifungal resistance and susceptibility (4 papers), Antibiotic Use and Resistance (3 papers) and Diphtheria, Corynebacterium, and Tetanus (2 papers). The work is most often cited by research in Molecular Medicine (364 citations), Clinical Biochemistry (292 citations), Applied Microbiology and Biotechnology (82 citations), Infectious Diseases (379 citations) and Endocrinology (89 citations). Deborah Ashcraft has collaborated with scholars based in United States, Australia and Jordan. Frequent co-authors include George A. Pankey, K E Aldridge, Kenneth E. Aldridge, Carl L. Pierson, Stephen G. Jenkins, Jon E. Rosenblatt, K M Cambre, David J. Farrell, Rodrigo E. Mendes and Lalitagauri M. Deshpande. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Diagnostic Microbiology and Infectious Disease, Journal of Investigative Medicine, Journal of Clinical Microbiology and Medical Mycology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.